CORC

浏览/检索结果: 共44条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Screening and characterization of inhibitory vNAR targeting nanodisc-assembled influenza M2 proteins 期刊论文
ISCIENCE, 2023, 卷号: 26, 期号: 1, 页码: 21
作者:  Yu, Chuandi;  Ding, Wen;  Zhu, Lei;  Zhou, Yuhang;  Dong, Yingkui
收藏  |  浏览/下载:10/0  |  提交时间:2023/12/13
Solubilization, purification, and ligand binding characterization of G protein-coupled receptor SMO in native membrane bilayer using styrene maleic acid copolymer 期刊论文
PEERJ, 2022, 卷号: 10
作者:  Zhu, Lina;  Zhao, Hongxin;  Wang, Yizhuo;  Yu, Chuandi;  Liu, Juanjuan
收藏  |  浏览/下载:12/0  |  提交时间:2022/12/23
Circulating DNA-Based Sequencing Guided Anlotinib Therapy in Non-Small Cell Lung Cancer 期刊论文
2019, 卷号: 6, 期号: 19, 页码: 1900721
作者:  Lu Jun;  Zhong Hua;  Wu Jun;  Chu Tianqing;  Zhang Lele
收藏  |  浏览/下载:13/0  |  提交时间:2020/01/03
Correlation Between Uptake of F-18-FDG During PET/CT and Ki-67 Expression in Patients Newly Diagnosed With Multiple Myeloma Having Extramedullary Involvement 期刊论文
2019, 卷号: 18, 页码: 1533033819849067
作者:  Li, Qian;  Ma, Jing;  Li, Han;  Xu, Wengui;  Cao, Zeng
收藏  |  浏览/下载:9/0  |  提交时间:2020/01/03
A nanopump for low-temperature and efficient solar water evaporation 期刊论文
JOURNAL OF MATERIALS CHEMISTRY A, 2019, 卷号: 7, 页码: 24311-24319
作者:  Zhao, Yujie;  Zhao, Kaiqi;  Yin, Junwen;  Yang, Jieying;  Xu, Jie
收藏  |  浏览/下载:9/0  |  提交时间:2019/12/30
Delayed enucleation of eyes with advanced intraocular retinoblastoma increases metastatic death 会议论文
Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), APR 28-MAY 02, 2019
作者:  Feng, Zhao Xun;  Wei, Meirong;  Liu, Guohua;  Solarte, Carlos;  Li, Bin
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/31
Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment 期刊论文
CANCER BIOLOGY & MEDICINE, 2018, 卷号: 15, 期号: 4
作者:  Wang, Jing;  Zhao, Yizhuo;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/04
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer The ALTER 0303 Phase 3 Randomized Clinical Trial 期刊论文
JAMA ONCOLOGY, 2018, 卷号: 4, 期号: 11
作者:  Han, Baohui;  Li, Kai;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/04
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer: The ALTER 0303 Phase 3 Randomized Clinical Trial. 期刊论文
JAMA Oncology, 2018, 卷号: 4, 期号: 11, 页码: 1569-1575
作者:  Han, Baohui*;  Li, Kai*;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/03
Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302) 期刊论文
British Journal of Cancer, 2018, 卷号: 118, 期号: 5, 页码: 654-661
作者:  Han, Baohui*;  Li, Kai;  Zhao, Yizhuo;  Li, Baolan;  Cheng, Ying
收藏  |  浏览/下载:9/0  |  提交时间:2019/12/03


©版权所有 ©2017 CSpace - Powered by CSpace